Recent findings on miR‑370 expression, regulation and functions in cancer (Review).
- Published in:
- Oncology Reports, 2023, v. 49, n. 4, p. N.PAG, doi. 10.3892/or.2023.8516
- By:
- Publication type:
- Article
Works matching IS 1021335X AND DT 2023 AND VI 49 AND IP 4
Results: 16
1
2
High expression of LY6E is an independent prognostic factor of colorectal cancer patients.
- Published in:
- Oncology Reports, 2023, v. 49, n. 4, p. N.PAG, doi. 10.3892/or.2023.8517
- By:
- Publication type:
- Article
3
Radiation prevents tumor progression by inhibiting the miR‑93‑5p/EphA4/NF‑κB pathway in triple‑negative breast cancer.
- Published in:
- Oncology Reports, 2023, v. 49, n. 4, p. N.PAG, doi. 10.3892/or.2023.8515
- By:
- Publication type:
- Article
4
Key genes expressed in mitochondria‑endoplasmic reticulum contact sites in cancer (Review).
- Published in:
- Oncology Reports, 2023, v. 49, n. 4, p. N.PAG, doi. 10.3892/or.2023.8514
- By:
- Publication type:
- Article
5
In ovo chorioallantoic membrane assay as a xenograft model for pediatric rhabdomyosarcoma.
- Published in:
- Oncology Reports, 2023, v. 49, n. 4, p. N.PAG, doi. 10.3892/or.2023.8513
- By:
- Publication type:
- Article
6
The Hedgehog/GLI signaling pathway activates transcription of Slug (Snail2) in melanoma cells.
- Published in:
- Oncology Reports, 2023, v. 49, n. 4, p. N.PAG, doi. 10.3892/or.2023.8512
- By:
- Publication type:
- Article
7
Xiaotan Sanjie decoction normalizes tumor permissive microenvironment in gastric cancer (Review).
- Published in:
- Oncology Reports, 2023, v. 49, n. 4, p. N.PAG, doi. 10.3892/or.2023.8511
- By:
- Publication type:
- Article
8
[Retracted] Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway.
- Published in:
- Oncology Reports, 2023, v. 49, n. 4, p. N.PAG, doi. 10.3892/or.2023.8510
- By:
- Publication type:
- Article
9
Andrographolide suppresses aerobic glycolysis and induces apoptotic cell death by inhibiting pyruvate dehydrogenase kinase 1 expression.
- Published in:
- Oncology Reports, 2023, v. 49, n. 4, p. N.PAG, doi. 10.3892/or.2023.8509
- By:
- Publication type:
- Article
10
p‑STAT3 influences doxorubicin and etoposide resistance of A549 cells grown in an in vitro 3D culture model.
- Published in:
- Oncology Reports, 2023, v. 49, n. 4, p. N.PAG, doi. 10.3892/or.2023.8508
- By:
- Publication type:
- Article
11
[Corrigendum] miR‑195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression.
- Published in:
- Oncology Reports, 2023, v. 49, n. 4, p. N.PAG, doi. 10.3892/or.2023.8507
- By:
- Publication type:
- Article
12
Diverse roles of UBE2T in cancer (Review).
- Published in:
- Oncology Reports, 2023, v. 49, n. 4, p. N.PAG, doi. 10.3892/or.2023.8506
- By:
- Publication type:
- Article
13
[Retracted] Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen‑activated protein kinase signalling pathway.
- Published in:
- Oncology Reports, 2023, v. 49, n. 4, p. N.PAG, doi. 10.3892/or.2023.8505
- By:
- Publication type:
- Article
14
Clinical significance of L1CAM expression and its biological role in the progression of oral squamous cell carcinoma.
- Published in:
- Oncology Reports, 2023, v. 49, n. 4, p. N.PAG, doi. 10.3892/or.2023.8504
- By:
- Publication type:
- Article
15
Increased expression of GIPC2 in colon adenocarcinoma is associated with a favorable prognosis and high levels of immune cell infiltration.
- Published in:
- Oncology Reports, 2023, v. 49, n. 4, p. N.PAG, doi. 10.3892/or.2023.8503
- By:
- Publication type:
- Article
16
[Corrigendum] METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression.
- Published in:
- Oncology Reports, 2023, v. 49, n. 4, p. N.PAG, doi. 10.3892/or.2023.8502
- By:
- Publication type:
- Article